UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

 

FORM 8-K

_________________

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 12, 2026

_______________________________

 

UPEXI, INC.

(Exact name of registrant as specified in its charter)

_______________________________

 

Delaware

 

001-40535

 

83-3378978

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

3030 N. Rocky Point Drive, Suite 420

Tampa, FL 33607

(Address of Principal Executive Offices) (Zip Code)

 

(727) 287-2800

(Registrant's telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

_______________________________

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.00001

 

UPXI

 

NASDAQ

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

On May 12, 2026, Upexi, Inc. (the "Company") issued a press release announcing its financial results for the fiscal third quarter ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

The information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.

Exhibit Description

99.1

Press Release dated May 12, 2026

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL Document)

 

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

UPEXI, INC.

 

 

 

 

 

Dated: May 13, 2026

 

/s/ Andrew J. Norstrud

 

 

 

Name: Andrew J. Norstrud

 

 

 

Title: Chief Financial Officer

 

 

3

EXHIBIT 99.1

 

Upexi Reports Fiscal Third Quarter 2026 Financial Results

 

Solana Tokens Held Increased During the Quarter by ~189,000 or 9% (35% Annualized)

 

Digital Asset Revenue Totaled $3.5 Million for the Quarter

 

Conference Call Scheduled for Today, May 12, 2026, at 5:30 p.m. Eastern Time

 

TAMPA, Fla., May 12, 2026— Upexi, Inc. (NASDAQ: UPXI) (the “Company” or “Upexi”), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced its financial results for the fiscal third quarter ended March 31, 2026.

 

“This quarter’s results reflect diligently executing against our digital asset treasury strategy of accumulating SOL on an accretive per-share basis and maintaining a flexible capital structure that positions us to pursue opportunities as they emerge,” said Allan Marshall, Chief Executive Officer of Upexi. “During the quarter, we grew the number of SOL held in our treasury by 9%, increased the number of tokens generated from staking, and repurchased approximately 2.5 million Upexi shares in the open market, all of which increased our Solana per share. Solana's best-in-class performance, costs, and institutional adoption gives us conviction that we are building long-term shareholder value around the network that we believe will revolutionize global finance.”     

 

Financial Highlights for the Quarter Ended March 31, 2026

 

·

Total revenue for the quarter was approximately $4.6 million, compared to $3.2 million for the same quarter ended March 31, 2025.

 

·

Gross profit totaled $4.4 million, up 179% year-over-year, due to the addition of the digital asset treasury business.

 

·

Net loss totaled $109.3 million, or $1.67 per share, compared to a net loss of $3.8 million, or $2.87 per share, for the quarter ended March 31, 2025. This net loss was largely driven by $92.3 million of unrealized losses on digital assets, reflecting non-cash quarter-end fair value adjustments.

 

·

Cash and cash equivalents increased to $3.5 million as of March 31, 2026.

 

·

Reduced short term debt by approximately $7.6 million, including approximately $5.4 million in short term treasury debt.

 

Operational and Other Highlights During and Subsequent to the Quarter

 

·

In the nine months ended March 31, 2026, the Company repurchased and retired 2,894,287 shares of Upexi common stock under the current repurchase program.

 

·

Completed $36 million private placement convertible note in exchange for 265,500 locked Solana tokens.

 

·

Completed $7.4 million registered direct offering.

 

·

Reduced ongoing operational costs, including the reduction of the employee count to 10 employees, the elimination of a warehouse lease and the elimination of several other general and administrative costs.

 

·

Management estimates that by July 1, 2026, the ongoing cash expenses for operations and interest will be less than the treasury’s staking revenue at the current price of Solana.

 

 

 

 

The Company’s Quarterly Report on Form 10-Q for this period is available on the SEC’s website and on Upexi’s IR website.

 

Conference Call Information

 

Event:

Fiscal Third Quarter 2026 Earnings Call

Date:

Tuesday, May 12, 2026

Time:

5:30 p.m. ET

Live Call:

1-877-407-9716 (U.S. Toll-Free) or 1-201-493-6779 (International)

Webcast

https://ir.upexi.com/news-events/ir-calendar

 

 

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until May 26, 2026, and can be accessed by dialing 1-844-512-2921 (U.S. Toll Free) or 1-412-317-6671 (International) and entering replay pin number: 13760532.

 

About Upexi, Inc.

Upexi, Inc. (Nasdaq: UPXI) is a leading digital asset treasury company, where it aims to acquire and hold as much Solana (SOL) as possible in a disciplined and accretive fashion. In addition to benefiting from the potential price appreciation of Solana - the cryptocurrency of the leading high-performance blockchain - Upexi utilizes three key value accrual mechanisms in intelligent capital issuance, staking, and discounted locked token purchases. The Company operates in a risk-prudent fashion to position itself for any market environment and to appeal to investors of all kinds, and it currently holds over two million SOL. Upexi also continues to be a brand owner specializing in the development, manufacturing, and distribution of consumer products. Please see www.upexi.com for more information.

 

Follow Upexi on X - https://x.com/upexitreasury

Follow CEO, Allan Marshall, on X - https://x.com/upexiallan

Follow CSO, Brian Rudick, on X - https://x.com/thetinyant

 

Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. For example, the Company is using forward looking statements when it discusses the anticipated use of proceeds. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with business strategy, potential acquisitions, revenue guidance, product development, integration, and synergies of acquiring companies and personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward- looking statements. Although we believe that the beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

 

Company Contact

Brian Rudick, Chief Strategy Officer

Email: brian.rudick@upexi.com

Phone: (203) 442-5391

 

Investor Contact

KCSA Strategic Communications

Valter Pinto or Jack Perkins

Upexi@KCSA.com

 

 

 

 

UPEXI, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

 

 

 

March 31,

 

 

June 30,

 

 

 

2026

 

 

2025

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash

 

$ 3,482,847

 

 

$ 2,975,150

 

Accounts receivable, net

 

 

496,393

 

 

 

157,515

 

Inventory, net

 

 

215,237

 

 

 

1,152,870

 

Due from VitaMedica transition

 

 

336,239

 

 

 

228,017

 

Prepaid expenses and other receivables

 

 

990,957

 

 

 

350,836

 

Current digital assets at fair value

 

 

114,942,784

 

 

 

49,913,655

 

Purchase price receivable - VitaMedica

 

 

1,340,000

 

 

 

2,000,000

 

Total current assets

 

 

121,804,457

 

 

 

56,778,043

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

241,215

 

 

 

2,052,573

 

Intangible assets, net

 

 

855,543

 

 

 

163,113

 

Goodwill

 

 

673,854

 

 

 

848,854

 

Deferred tax asset

 

 

5,948,858

 

 

 

5,948,858

 

Digital assets at fair value, net of current

 

 

69,960,104

 

 

 

56,083,525

 

Other assets

 

 

178,589

 

 

 

192,123

 

Right-of-use asset, net

 

 

711,063

 

 

 

1,739,755

 

Total noncurrent assets

 

 

78,569,226

 

 

 

67,028,801

 

 

 

 

 

 

 

 

 

 

Total assets

 

$ 200,373,683

 

 

$ 123,806,844

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Accounts payable

 

$ 288,722

 

 

$ 1,039,370

 

Accrued compensation

 

 

4,506,613

 

 

 

3,470,296

 

Deferred revenue

 

 

2,324

 

 

 

13,155

 

Accrued liabilities

 

 

2,166,822

 

 

 

356,064

 

Accrued interest

 

 

2,268,473

 

 

 

792,449

 

Acquisition payable

 

 

260,652

 

 

 

260,652

 

Current portion of promissory notes

 

 

-

 

 

 

560,000

 

Short-term treasury debt

 

 

57,295,723

 

 

 

20,000,000

 

Current portion of Cygnet subsidiary notes payable

 

 

3,694,721

 

 

 

5,380,910

 

Current portion of operating lease payable

 

 

339,669

 

 

 

691,010

 

Total current liabilities

 

 

70,823,719

 

 

 

32,563,906

 

 

 

 

 

 

 

 

 

 

Operating lease payable, net of current portion

 

 

437,077

 

 

 

1,145,440

 

Convertible notes payable

 

 

181,031,073

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Total long-term liabilities

 

 

181,468,150

 

 

 

1,145,440

 

 

 

 

 

 

 

 

 

 

Stockholders' equity

 

 

 

 

 

 

 

 

Preferred stock, $0.00001 par value, 10,000,000 shares authorized, and 150,000 shares issued and outstanding

 

 

2

 

 

 

2

 

Common stock, $0.00001 par value, 1,000,000,000 shares authorized, 66,895,799 and 38,270,571 shares issued, as of March 31, 2026 and June 30, 2025, respectively

 

 

669

 

 

 

383

 

Additional paid in capital

 

 

230,145,603

 

 

 

150,640,935

 

Accumulated deficit

 

 

(282,064,460 )

 

 

(60,543,822 )

Total stockholders' equity

 

 

(51,918,186 )

 

 

90,097,498

 

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders' equity

 

$ 200,373,683

 

 

$ 123,806,844

 

 

 

 

 

 

UPEXI, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

 

 

 

Three Months Ended March 31,

 

 

Nine Months Ended March 31,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$ 1,050,667

 

 

$ 3,160,480

 

 

$ 7,115,322

 

 

$ 11,522,487

 

Digital asset revenue

 

 

3,506,432

 

 

 

-

 

 

 

14,733,562

 

 

 

-

 

Total revenue

 

 

4,557,099

 

 

 

3,160,480

 

 

 

21,848,884

 

 

 

11,522,487

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

206,365

 

 

 

1,601,374

 

 

 

2,503,991

 

 

 

4,059,207

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

4,350,734

 

 

 

1,559,106

 

 

 

19,344,893

 

 

 

7,463,280

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

 

553,300

 

 

 

1,039,299

 

 

 

2,536,696

 

 

 

3,030,687

 

Distribution costs

 

 

588,652

 

 

 

990,049

 

 

 

2,400,449

 

 

 

3,722,196

 

General and administrative

 

 

4,931,678

 

 

 

2,642,654

 

 

 

19,711,672

 

 

 

5,558,934

 

Unrealized loss on digital assets

 

 

92,307,488

 

 

 

5,268

 

 

 

178,806,383

 

 

 

5,268

 

Realized loss on digital asset revenue conversion to USD

 

 

1,887,472

 

 

 

-

 

 

 

2,229,071

 

 

 

-

 

Realized loss on sale of digital assets

 

 

6,773,418

 

 

 

-

 

 

 

6,773,418

 

 

 

-

 

Stock-based compensation

 

 

3,987,514

 

 

 

521,353

 

 

 

18,044,585

 

 

 

695,229

 

Amortization of acquired intangible assets

 

 

19,190

 

 

 

19,191

 

 

 

57,570

 

 

 

57,571

 

Impairment on assets from manufacturing shut down

 

 

-

 

 

 

-

 

 

 

1,422,289

 

 

 

-

 

Depreciation

 

 

88,289

 

 

 

198,519

 

 

 

358,579

 

 

 

658,986

 

Lease Impairment (gain on settlement)

 

 

-

 

 

 

(269,994 )

 

 

-

 

 

 

(269,994 )

 

 

 

111,137,001

 

 

 

5,146,339

 

 

 

232,340,712

 

 

 

13,458,877

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(106,786,267 )

 

 

(3,587,233 )

 

 

(212,995,819 )

 

 

(5,995,597 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expense, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

(3,683,334 )

 

 

(245,103 )

 

 

(9,987,426 )

 

 

(763,626 )

Other income, net

 

 

1,125,771

 

 

 

676

 

 

 

1,462,607

 

 

 

676

 

Other expense, net

 

 

(2,557,563 )

 

 

(244,427 )

 

 

(8,524,819 )

 

 

(762,950 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss on operations before income tax

 

 

(109,343,830 )

 

 

(3,831,660 )

 

 

(221,520,638 )

 

 

(6,758,547 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax benefit (expense)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$ (109,343,830 )

 

$ (3,831,660 )

 

$ (221,520,638 )

 

$ (6,758,547 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic loss per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per share

 

$ (1.67 )

 

$ (2.87 )

 

$ (3.66 )

 

$ (5.92 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted loss per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per share

 

$ (1.67 )

 

$ (2.87 )

 

$ (3.66 )

 

$ (5.92 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

 

65,506,837

 

 

 

1,336,373

 

 

 

60,522,907

 

 

 

1,140,995

 

Fully diluted weighted average shares outstanding

 

 

65,506,837

 

 

 

1,336,373

 

 

 

60,522,907

 

 

 

1,140,995